Form 4: Recursion CFO Reports Tax-Related Share Withholding
Statement of Changes in Beneficial Ownership
Recursion Pharmaceuticals CFO Ben R. Taylor disposed of 5,396 shares to satisfy tax obligations related to restricted stock units.
Summary
- CFO Ben R. Taylor executed a transaction involving 5,396 shares of Class A Common Stock.
- The transaction was a mandatory tax withholding event associated with the vesting of restricted stock units.
- Following the transaction, the reporting person maintains a beneficial ownership of 1,101,876 shares.
- The shares were valued at $3.15 per share for the purpose of the tax settlement.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it is a routine administrative tax transaction rather than a discretionary sale of stock.
Positives
- The transaction is a routine administrative event related to tax compliance rather than a discretionary market sale.
- The reporting person retains a significant equity stake of over 1.1 million shares.
Negatives
- The transaction represents a reduction in the direct share ownership of a key executive.
Risks
- Reliance on equity-based compensation can lead to periodic selling pressure during tax settlement events.
Future Outlook
No forward-looking guidance provided in this filing.
Industry Context
StockSavvy.ai notes that tax-related share withholding is a standard corporate governance practice for executives receiving equity compensation and does not typically signal a change in management sentiment regarding company performance.
Comparison to Industry Standards
- The transaction aligns with standard executive compensation practices in the biotechnology sector.
- Net settlement of restricted stock units is a common mechanism used by publicly traded companies to manage tax liabilities for employees.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a standard tax-related settlement.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 06/15/2026 | Date of the transaction involving the withholding of shares. |
| 06/17/2026 | Date of the filing of the Form 4. |
Keywords
Recursion Pharmaceuticals, RXRX, Insider Trading, Form 4, CFO, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.